Search clinical trials for: 124I-18B10(10L) PET/CT

Total 1774 results

Peking University Cancer Hospital & Institute

Active, not recruiting

CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors

Gastrointestinal Cancer

China
Memorial Sloan Kettering Cancer Center

Active, not recruiting

PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study

Newly Diagnosed or Recurrent Metastatic Melanoma Patients | Malignant Brain Tumors

United States
Jonsson Comprehensive Cancer Center
ImaginAb, Inc.

Completed

Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer

Pancreatic Cancer | Prostate Cancer | Bladder Cancer

United States
Peking Union Medical College Hospital
Peking University Cancer Hospital & Institute

Recruiting

Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

China
Miguel Pampaloni
Molecular Insight Pharmaceuticals, Inc.; Jubilant DraxImage Inc.

Terminated

124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study

Neuroblastoma

United States
prof. dr. Koen Van Laere
Universitaire Ziekenhuizen KU Leuven; KU Leuven; University Hospital, Ghent; Fund...

Not yet recruiting

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. AD

Parkinson Disease | Alzheimer Disease | Dementia With Lewy Bodies | MSA - Multiple System Atrophy

Belgium
Peregrine Pharmaceuticals

Terminated

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Malignant Solid Tumor

United States
Heidelberg Pharma AG

Completed

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

Kidney Cancer | Renal Cell Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Thyroid Carcinoma | Metastatic Thyroid Carcinoma

United States
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Assistance Publique Hopitaux De Marseille

Terminated

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

Breast Carcinoma

France
Peter MacCallum Cancer Centre, Australia
Melbourne Health; Westmead Hospital; Victorian Infectious Diseases Reference...

Completed

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia (PIPPIN)

Acute Myeloid Leukemia | Febrile Neutropenia | Acute Lymphoblastic Leukemia | Haematopoietic Stem Cell Transplant, Autologous | Haematopoietic Stem Cell Transplant, Allogeneic

Australia
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Washington University School of Medicine

Terminated

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

United States
Sun Yat-sen University

Unknown

Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Aposense Ltd.

Completed

18F ML-10 for Early Detection of Response of Brain Metastases to WBRT

Solid Tumors | Brain Metastases
University of Utah
National Cancer Institute (NCI)

Completed

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Venothromboembolism

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M) | Untreated Bone Metastases

United States
HALO Diagnostics

Completed

A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer

Prostate Cancer

United States
Massachusetts General Hospital
National Cancer Institute (NCI)

Completed

Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

Chordoma

United States
Advanced Imaging Projects, LLC
All India Institute of Medical Sciences, New Delhi; US Department of Veterans... and other collaborators

Not yet recruiting

Safety and Efficacy of Ga68 Αvβ3 IAC PET/CT for Diagnosis and Clinical Management in Angiogenic Breast Cancer Patients (Shiva)

Angiogenic Breast Cancer

South Africa, India
The Catholic University of Korea

Unknown

Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System

Cancer | Solid Tumors

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
University of Vermont

Terminated

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

Prostatic Neoplasm

United States
University College, London
King's College London; Rambam Health Care Campus; University of Melbourne; Menzies... and other collaborators

Not yet recruiting

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia (PET-SAB)

Sepsis | Staphylococcus Aureus Infection | Bloodstream Infection | Staphylococcus Aureus Bacteremia | Sepsis Bacterial | Staphylococcus Aureus Septicemia | Staph Sepsis
Ontario Clinical Oncology Group (OCOG)
Cancer Care Ontario

Active, not recruiting

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging (PET MUSE)

Muscle-invasive Bladder Cancer

Canada
Herlev Hospital

Completed

Diagnostic Imaging of Myeloma Bone Lesions (RAMP)

Multiple Myeloma

Denmark
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics

Breast Neoplasms | Prostatic Neoplasms
University of Pittsburgh

Terminated

Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer

Carcinoma, Squamous Cell of Head and Neck

United States
Massachusetts General Hospital

Recruiting

Evaluation of PET/MRI in Children With Cancer

Hematologic Malignancy

United States
Xuzhou Medical University

Unknown

PET-CT/MRI in the Radiotherapy for Prostate Cancer

Prostate Cancer
Massachusetts General Hospital

Unknown

PET-CT vs. Integrated MR-PET Scanning of GYN Cancers

Cervical Cancer | Ovarian Cancer | Endometrial Cancer

United States
M.D. Anderson Cancer Center

Completed

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Melanoma

United States
University Hospital of North Norway

Terminated

PET/MR Imaging in Lung Cancer

Lung Cancer

Norway
NYU Langone Health
Dendreon

Terminated

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
Insel Gruppe AG, University Hospital Bern

Recruiting

Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System (ULD-PET)

PET/CT

Switzerland
University of Sao Paulo

Unknown

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Rectal Cancer

Brazil
Turku University Hospital
GE Healthcare; Blue Earth Diagnostics

Completed

Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro)

Prostate Carcinoma

Finland
Aya Khaled Mahmoud

Not yet recruiting

Role of PET/CT in Peritoneal Deposits Assessment

Peritoneal Metastases
Johns Hopkins University

Recruiting

PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography] (PET; CT)

Coronary Artery Disease | Atherosclerosis | Coronary Atherosclerosis of Native Coronary Artery

United States
University Hospital, Ghent

Recruiting

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

Breast Neoplasms | Breast Cancer Female

Belgium
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; The University of Queensland

Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer (IMAGE)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Australia
Assistance Publique Hopitaux De Marseille

Completed

Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation (DOTATATE)

Paragangliomas | Pheochromocytomas

France
AHS Cancer Control Alberta
University of Calgary; Calgary Health Region

Completed

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Squamous Cell Cancer

Canada
Zhongnan Hospital

Unknown

Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients

Oral Cancer | Radiotherapy; Complications
University of Calgary
Tom Baker Cancer Centre

Completed

PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer

Head and Neck Cancer

Canada
Rigshospitalet, Denmark

Completed

Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Unknown Primary Tumor

Denmark

Search clinical trials for: 124I-18B10(10L) PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations